Brown & Brown, Inc. Q2 FY26 Earnings Analysis

Published 29 May 2026 | Insurance | Market Cap: ₹19.3K Cr

Price

56.84

Market Cap

₹19.3K Cr

P/E Ratio

18.6

Revenue Rank

Rank 4

Margin Rank

Rank 2

Earnings Summary

- Expect modest organic growth improvement each quarter this year compared to Q1, particularly in specialty distribution, driven by less CAT property placements and increased casualty business through the 180 segment. - Earnings per share (EPS) grew nearly 8% to $1.39 in Q1 2026.

📊 Revenue & Sales Performance

Rank 4

- Expect modest organic growth improvement each quarter this year compared to Q1, particularly in specialty distribution, driven by less CAT property placements and increased casualty business through the 180 segment. (Page 3) - Anticipate flat organic growth excluding contingents in Q2 due to heavy CAT property placement weighting; improving growth expected in second half of the year. (Page 3) - Sequential revenue growth improvement expected with an upper bound of about 2.5% organic growth in the back half of the year. (Page 10) - AI investments seen as a positive driver for revenue growth, improving customer experience and identifying growth opportunities. (Pages 14, 17) - Contingent commissions expected to increase this year, contributing to revenue stability and margin growth. (Pages 3, 8, 14) - Integration of Accession acquisition expected to add $180 million in revenues, diversifying product mix and providing more stable organic growth over time. (Pages 3,10)

📈 Profitability & Margins

Rank 2

- Earnings per share (EPS) grew nearly 8% to $1.39 in Q1 2026. - Adjusted EBITDAC margin increased 40 basis points to 38.5% in Q1 2026. - Organic revenue growth expected to improve modestly each quarter compared to Q1. - Specialty Distribution anticipates relatively flat organic growth excluding contingents in Q2, with improving growth in the second half of the year. - The addition of the $180 million Accession business is expected to contribute positively to organic growth and specialty distribution in the back half of 2026. - Contingent commissions are anticipated to be up for the entire company in 2026, driven by underwriting profitability. - Adjusted EBITDAC margin for Accession business expected around 35% for the full year. - Sequential quarterly organic growth improvements projected but likely upper bound around 2.5% in later quarters.

🏗️ Capital Expenditure Plans

Yes

- The company continues to invest in high-quality people to deliver customer solutions. - Significant ongoing investments in technology, data, and artificial intelligence capabilities to drive revenue growth, improve customer experience, and enhance teammate productivity. - Focus on building an AI-powered organization with enterprise capabilities, world-class data and AI talent, enterprise-grade technologies, and partnerships with technology firms. - Combination of internal AI development and partnering with external vendors to accelerate progress. - Strategic investments include acquisitions of smaller or specialized firms that fit culturally and make financial sense. - Capital deployment prioritized towards deleveraging, share repurchases, dividends, technology enhancements, and M&A opportunities. - Integration investments in acquisitions like Accession are focused on synergy realization, collaboration, and leveraging capabilities to win and retain customers.

💰 Fundraising & Capital Structure

No information

- The company has a strong balance sheet and cash flow, focusing on delevering. - Their capital deployment priorities include share repurchases, M&A, dividends, and delevering. - There is no specific mention of new fundraising through debt or equity in the current or near future. - The company is actively using cash flow for $350 million in stock repurchases and increasing dividends by 10% compared to the prior year. - They intend to continue investing in technology, acquisitions, and share repurchases with existing capital. - Overall, the company appears focused on maintaining financial strength rather than raising new debt or equity at this time.

📋 Order Book & Pipeline

No information

The document does not provide explicit details on current or expected orderbook or pending orders in a direct financial or manufacturing sense. However, related insights include: - Organic revenue growth is flat year-over-year, with a positive impact from contingents increasing by 2.2%. - Specialty Distribution expects relatively flat organic growth excluding contingents in Q2, with improving growth anticipated in the second half of the year. - Integration of Accession is progressing on track, aiming to deliver $30 million to $40 million EBITDA synergies this year. - The new sales model blending regional and local approaches shows early signs of increased activity, generating optimism for the second half of the year and into 2027. - No explicit quantitative backlog or pending order figures are disclosed.

Key Metrics

Revenue

Rank 4

Margin

Rank 2

Capex

Yes

Fundraise

No information

Order Book

No information

Frequently Asked Questions

What were Brown & Brown, Inc. Q2 FY26 results?

- Expect modest organic growth improvement each quarter this year compared to Q1, particularly in specialty distribution, driven by less CAT property placements and increased casualty business through the 180 segment. - Earnings per share (EPS) grew nearly 8% to $1.39 in Q1 2026.

What is Brown & Brown, Inc. share price analysis?

Brown & Brown, Inc. currently shows a neutral. The stock trades at a P/E of 18.6 with a market cap of $19,266. Investors should review the full earnings analysis for detailed insights.

Is Brown & Brown, Inc. planning capital expenditure?

- The company continues to invest in high-quality people to deliver customer solutions.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.